Ian E. Templeton
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
-
- Drug Transport and Resistance Mechanisms
Papers in
- Pharmacology 13
- Pharmacogenetics and Drug Metabolism 12
- Oncology 11
- Drug Transport and Resistance Mechanisms 9
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Nina Isoherranen (3 shared papers)Kent L. Kunze (3 shared papers)Kenneth E. Thummel (3 shared papers)Luna Musib (3 shared papers)C. Davis (2 shared papers)Nicholas S. Jones (1 shared paper)Wendel L. Nelson (1 shared paper)Christine Hoffer (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (5 papers)The AAPS Journal (2 papers)Drug Metabolism and Disposition (2 papers)Phytotherapy Research (1 paper)Xenobiotica (1 paper)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Ian E. Templeton
18 papers receiving 402 citations
Peers
Comparison fields: 5 of 79
- Pharmacology 212
- Oncology 118
- Pediatrics, Perinatology and Child Health 80
- Computational Theory and Mathematics 53
- Complementary and alternative medicine 26
Countries citing papers authored by Ian E. Templeton
This map shows the geographic impact of Ian E. Templeton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian E. Templeton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian E. Templeton more than expected).
Fields of papers citing papers by Ian E. Templeton
This network shows the impact of papers produced by Ian E. Templeton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian E. Templeton. The network helps show where Ian E. Templeton may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian E. Templeton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 103 | |
| 2 | 2011 | 63 | |
| 3 | 2018 | 58 | |
| 4 | 2010 | 54 | |
| 5 | 2005 | 30 | |
| 6 | 2006 | 26 | |
| 7 | 2011 | 17 | |
| 8 | 2015 | 17 | |
| 9 | 2015 | 11 | |
| 10 | 2023 | 8 | |
| 11 | 2014 | 8 | |
| 12 | 2023 | 6 | |
| 13 | 2020 | 6 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 3 | |
| 17 | 2020 | 2 | |
| 18 | 2025 | 1 |
About Ian E. Templeton
Ian E. Templeton is a scholar working on Pharmacology, Oncology, Molecular Biology, Pediatrics, Perinatology and Child Health and Pharmaceutical Science, having authored 18 papers that have together received 421 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (9 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer therapeutics and mechanisms (2 papers), Melanoma and MAPK Pathways (2 papers), Drug Solubulity and Delivery Systems (1 paper), Pharmacological Effects and Toxicity Studies (1 paper) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Pharmacology (212 citations), Oncology (118 citations), Pediatrics, Perinatology and Child Health (80 citations), Computational Theory and Mathematics (53 citations) and Complementary and alternative medicine (26 citations). Ian E. Templeton has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Nina Isoherranen, Kent L. Kunze, Kenneth E. Thummel, Luna Musib, C. Davis, Nicholas S. Jones, Wendel L. Nelson, Christine Hoffer, E D Kharasch and J. Brian Houston. Their work appears in journals such as Clinical Pharmacology & Therapeutics, The AAPS Journal, Drug Metabolism and Disposition, Phytotherapy Research and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.